DEFINITION of 'Investigational New Drug (IND)'

The first step in the drug review process by the U.S. Food and Drug Administration (FDA). An Investigational New Drug (IND) application is submitted by the company responsible for developing the drug (the sponsor) to the FDA. The IND is submitted after the sponsor has determined through animal studies that the proposed drug is reasonably safe for initial use in humans, and that it shows sufficient promise as a treatment to justify commercial development. The FDA reviews the IND application and decides whether it is safe for the company to progress to the next stage, i.e. clinical trials, wherein the drug is tested in humans. The sponsor has to wait for 30 calendar days after submitting the IND before commencing any clinical trials.

BREAKING DOWN 'Investigational New Drug (IND)'

INDs fall into two categories: 1. Commercial, submitted mainly by companies seeking marketing approval for a new drug. 2. Research (non-commercial).

The majority of INDs are filed for non-commercial research and are of three main types – Investigator IND, Emergency Use IND, and Treatment IND.

The IND application contains information in three broad areas –

  • Animal pharmacology and toxicology studies: contains the preclinical studies needed to establish whether the drug is reasonably safe for initial tests in humans, as well as any previous experience involving human use of the drug (such as in foreign markets).
  • Manufacturer information: includes information to ensure that the company can manufacture sufficient batches of the drug.
  • Clinical Protocols and Investigator Information: contains protocols to determine if the initial trials will expose human subjects to needless risks, and includes qualifications of the clinical investigators who will oversee administration of the compound.

An IND is also the avenue through which the sponsor gets from the FDA an exemption to the Federal law that prohibits an unapproved drug from being transported across state borders. This exemption is required since in most cases the sponsor will need to ship the investigational drug to investigators in other states.

Since it can cost hundreds of millions of dollars – and many years – to undertake the clinical trials necessary to bring a new drug to market, the IND application signifies that the sponsor is willing to make this huge investment. As such, investor reaction to an IND application – the first step in a long and arduous process for drug approval – filed by a company is typically neutral.

RELATED TERMS
  1. New Drug

    A new medication or therapy that has not been used before in ...
  2. Abbreviated New Drug Application ...

    A written request to the U.S. Food and Drug Administration to ...
  3. Phase 1

    Phase 1 clinical studies or clinical trials are focused on the ...
  4. Abbreviated New Drug Submission ...

    A written request to Health Canada to obtain marketing approval ...
  5. Orphan Drug Credit

    A federal tax credit that provides an incentive for pharmaceutical ...
  6. Phase 2

    The second phase of clinical trials or studies for an experimental ...
Related Articles
  1. Insights

    8 Stages Of New Drug Development

    Understanding biotech data isn't easy. What is a clinical trial, what are the various phases, and why do the results of these trials and applications often create double-digit moves in the price ...
  2. Investing

    It's No Accident That Drugs Are Expensive

    Branded drugs are expensive in large part because it's expensive and risky to develop them
  3. Investing

    Kite Pharma Moves to Begin Cancer Drug Phase 1

    Kite filed an FDA application to move its KITE-718 cancer drug into Phase 1 trials.
  4. Investing

    Evaluating Pharmaceutical Companies

    Learn how to find a healthy pharmaceutical investment in a market full of weak drugs.
  5. Investing

    Drug Prices: Name Brands Doubled in Last 5 Years (ESRX)

    Express Scripts' Drug Trends Report, released Monday, revealed that the average price of brand name drugs rose 16.2% in 2015, with over one third of brand name drugs seeing price increases over ...
  6. Investing

    Drug Giants May Benefit From China Drug Inclusion

    Pharma giants may see higher sales as the Chinese government subsidizes expensive prescription drugs.
  7. Investing

    Orphan Drug Rules Are Being Manipulated

    It may be the time to revamp the Orphan Drug Program amid concerns it's turning into a scam.
  8. Investing

    Cost of Old Cancer Drugs Rises in EU Amid Outcry

    The prices of several off-patent cancer drugs have soared more than 100% in Europe.
  9. Insights

    The Industry Handbook: Pharma Industry

    Learn about the pharmaceutical industry and discover the forces that influence this highly profitable and dynamic sector.
  10. Insurance

    The Cancer (and Other Drug) Shortage

    Your doctor may not tell you, but even in the U.S., life-saving drugs can be in short supply. Here's what to know and do.
RELATED FAQS
  1. How does government regulation impact the drugs sector?

    Learn about how drugs are regulated by the U.S. government as well as the role of the Food and Drug Administration during ... Read Answer >>
  2. Do financial advisors get drug tested?

    Learn how financial advisor regulatory bodies do not require drug testing but many individual firms that hire advisors do ... Read Answer >>
  3. What level of return on equity is average for a company in the drugs sector?

    Find out more about the drugs sector, which industries are included in the sector and the average return on equity for companies ... Read Answer >>
  4. What does it mean to have orphan drug status?

    In 1982, The U.S. Food and Drug Administration (FDA) recognized the lack of incentive for pharmaceutical companies to develop ... Read Answer >>
  5. What is the average price-to-earnings ratio in the drugs sector?

    Learn what the average price-to-earnings ratio is for companies operating in the drugs sector and why this metric is important ... Read Answer >>
Hot Definitions
  1. Ethereum

    Ethereum is a decentralized software platform that enables SmartContracts and Distributed Applications (ĐApps) to be built ...
  2. Cryptocurrency

    A digital or virtual currency that uses cryptography for security. A cryptocurrency is difficult to counterfeit because of ...
  3. Financial Industry Regulatory Authority - FINRA

    A regulatory body created after the merger of the National Association of Securities Dealers and the New York Stock Exchange's ...
  4. Initial Public Offering - IPO

    The first sale of stock by a private company to the public. IPOs are often issued by companies seeking the capital to expand ...
  5. Cost of Goods Sold - COGS

    Cost of goods sold (COGS) is the direct costs attributable to the production of the goods sold in a company.
  6. Profit and Loss Statement (P&L)

    A financial statement that summarizes the revenues, costs and expenses incurred during a specified period of time, usually ...
Trading Center